Chinese Psoriasis Real World Evidence Research
NCT04465838 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 10000
Last updated 2024-01-05
Summary
This research is a multicenter,observational study under real world settings in patients diagnosed as psoriasis by dermatologist in the clinic. As patient's choice of medication should be fully respected, all the patients can choose the treatments they prefer, like phototherapy, traditional systemic therapy or biologics. And the study was conducted to compare the effectiveness among different choices of medication in Chinese psoriasis patients.
Conditions
Interventions
- OTHER
-
NIS
This is a non-interventional study (NIS).
Sponsors & Collaborators
-
Second Affiliated Hospital, School of Medicine, Zhejiang University
lead OTHER
Eligibility
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2020-07-08
- Primary Completion
- 2030-07-13
- Completion
- 2030-07-30
Countries
- China
Study Locations
More Related Trials
-
A Study to Assess Treatment Patterns, Clinical Outcomes and Healthcare Resource Utilization Among Adult Participants With Moderate-To-Severe Plaque Psoriasis
NCT05547490 ·Status: COMPLETED
-
Safety and Efficacy of Etanercept in Patients With Psoriasis
NCT02258282 ·Status: UNKNOWN ·Phase: NA
-
COVID-19 Associated With Psoriasis
NCT05961605 ·Status: UNKNOWN
-
A Study of IBI112 in Chinese Patients With Psoriasis Who Were Previously Treated With Biologics
NCT05970978 ·Status: COMPLETED ·Phase: PHASE2
-
A Study to Evaluate the Efficacy and Safety of AK111 in Subjects With Moderate to Severe Plaque Psoriasis
NCT06066125 ·Status: COMPLETED ·Phase: PHASE3
-
A Study to Evaluate the Efficacy and Safety of CS32582 in Participants With Moderate to Severe Plaque Psoriasis
NCT07129382 ·Status: RECRUITING ·Phase: PHASE1/PHASE2
-
A Study to Investigate Efficacy and Safety of Apremilast 30 mg Twice Daily (BID) in Chinese Participants With Moderate to Severe Plaque-type Psoriasis (PsO)
NCT06122649 ·Status: COMPLETED ·Phase: PHASE3
-
A Real-world Study to Assess Safety and Effectiveness of Secukinumab in Pediatric Plaque Psoriasis Patients in China
NCT05388916 ·Status: COMPLETED
-
the Efficacy and Safety of Etanercept (Yi Sai Pu) in Chinese Patients With Moderate-to-Severe Psoriasis
NCT04912401 ·Status: RECRUITING
-
To Evaluate the Efficacy and Safety of Netakimab in Chinese Patients With Moderate to Severe Plaque Psoriasis
NCT07008547 ·Status: COMPLETED ·Phase: PHASE3
-
A Observational Study to Evaluate Deucravacitinib in Patients With Moderate Plaque Psoriasis in China
NCT06512337 ·Status: ACTIVE_NOT_RECRUITING
-
Immunoclassification of Psoriasis: a Strategy for Precision Medicine
NCT05503875 ·Status: RECRUITING ·Phase: NA
-
A Study to Evaluate Efficacy and Safety of HS-10374 for Mild-to-moderate Plaque Psoriasis
NCT06926582 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2
-
The Impact of Targeted Therapy on Microorganism in Patients With Psoriasis
NCT01504113 ·Status: UNKNOWN
-
Efficacy, Safety, Pharmacokinetics and Pharmacodynamics of ICP-488 in Patients with Moderate to Severe Plaque Psoriasis
NCT06109818 ·Status: COMPLETED ·Phase: PHASE2
-
An Investigational Study to Evaluate Experimental Medication BMS-986165 in Japanese Participants With Moderate-to-Severe Psoriasis
NCT03924427 ·Status: COMPLETED ·Phase: PHASE3
-
A Study to Evaluate the Efficacy and Safety of LZM012
NCT06110676 ·Status: RECRUITING ·Phase: PHASE3
-
The Relationship Between Moderate-to-severe Psoriasis and Sleep Disturbance
NCT06165887 ·Status: NOT_YET_RECRUITING
-
Ixekizumab Versus Secukizumab in Over 70-year-old Patients with Psoriasis
NCT06811558 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Efficacy, Safety, Pharmacokinetics of ICP-488 in Patients With Moderate to Severe Plaque Psoriasis
NCT06842199 ·Status: RECRUITING ·Phase: PHASE3
-
IBI112 in Moderate to Severe Plaque Psoriasis With Randomized Withdrawal and Re-treatment
NCT06049810 ·Status: COMPLETED ·Phase: PHASE3
-
A Phase 2 Study of Efficacy and Safety of AK111 in Subjects With Moderate-to-Severe Psoriasis
NCT05096364 ·Status: COMPLETED ·Phase: PHASE2
-
Clinical Study of AK101 in Subjects With Moderate to Severe Plaque Psoriasis
NCT04173637 ·Status: COMPLETED ·Phase: PHASE2
-
A Study of the Safety and Effectiveness of Ustekinumab (Stelara) in Chinese Patients With Psoriasis
NCT01008995 ·Status: COMPLETED ·Phase: PHASE3
-
A Phase II Efficacy and Safety Study of HSK44459 in Subjects With Moderate to Severe Plaque Psoriasis
NCT07150988 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2